Preoperative selective desensitization of live donor liver transplant recipients considering the degree of T lymphocyte cross-match titer, model for end-stage liver disease score, and graft liver volume.
In conclusion, this desensitization protocol for the selected recipients considering the degree of T lymphocyte cross-match titer, MELD score, and graft liver volume is feasible and safe.
PMID: 24851018 [PubMed - in process]
Source: J Korean Med Sci - Category: Journals (General) Authors: Hong G, Yi NJ, Suh SW, Yoo T, Kim H, Park MS, Choi Y, Lee K, Lee KW, Park MH, Suh KS Tags: J Korean Med Sci Source Type: research
More News: General Medicine | Liver | Liver Disease | Liver Transplant | Rituxan | Study | Transplant Surgery | Transplants | Urology & Nephrology